Interference sequence-modified TGF-beta1 silent leukemia cell exosome and preparation method and application thereof

A technology of leukemia cells and interfering sequences, applied in the biological field, can solve the problems of weak immunogenicity and poor clinical efficacy.

Inactive Publication Date: 2017-09-15
XIN HUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE
View PDF0 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, most patients do not benefit from treatment
Although unmodified tumor-derived exosomes can induce certain antigen-specific immune responses, their immunogenicity is relatively weak, and the clinical efficacy is still not optimistic.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Interference sequence-modified TGF-beta1 silent leukemia cell exosome and preparation method and application thereof
  • Interference sequence-modified TGF-beta1 silent leukemia cell exosome and preparation method and application thereof
  • Interference sequence-modified TGF-beta1 silent leukemia cell exosome and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0055] The present invention also provides the preparation method of the TGF-β1 silenced leukemia cell exosomes modified by the interference sequence comprising the following steps:

[0056] Step 1, culturing leukemia cells;

[0057] Step 2, preparing leukemia cells modified by interfering sequences;

[0058] Step 3, extraction and purification of exosomes.

[0059] Step 4, detecting the anti-leukemia effect of the modified leukemia cell exosomes targeting the sensitized dendritic cell vaccine as a protective tumor vaccine;

[0060]Step five, the effect detection of the dendritic cell vaccine targeted and sensitized by the modified leukemia cell exosomes in tumor-bearing mice.

[0061] Furthermore, Step 1 is specifically:

[0062] a. Configure 1640 complete medium containing 10% fetal bovine serum, which contains 100U / ml penicillin sodium and 100ug / ml streptomycin sulfate, and freeze the cryopreservation tube with L1210 cells from the liquid nitrogen tank After taking it o...

Embodiment 1

[0090] Example 1 Preparation of L1210-derived exosomes with down-regulated TGF-β1 content

[0091] 1. Construction of TGF-β1shRNA lentivirus

[0092] 1. Preparation of TGF-β1shRNA lentiviral vector

[0093] The TGF-β1 interference lentiviral vector was designed and synthesized by Shanghai Hanheng Biotechnology Co., Ltd. According to the TGF-β1 nucleotide sequence and siRNA in Genebank, three optimal target sequences were designed. Named shRNA1, shRNA2, shRNA3 respectively. The sequence is as follows. Simultaneously, an siRNA unrelated to the TGF-β1 gene sequence was synthesized as a negative control (Negative control), named shRNA NC. After sequence homology analysis, Shanghai Sangon Bio-synthesized double-stranded DNA Oligo containing interfering sequences, both ends of which contain enzyme cleavage site cohesive segments, which were ligated into the pHBLV-U6-Scramble-Zsgreen expression vector after enzyme cleavage. Transfer the ligated plasmid into Escherichia coli DH5a...

Embodiment 2

[0177] Example 2 Dendritic cell vaccine (DC LEX-TGF-β1si )

[0178] Induction of dendritic cells (DCs)

[0179] Isolation and culture of mouse bone marrow DC:

[0180] 1) Take three 6-8 week old mice, kill them, soak in 75% alcohol for 1 minute.

[0181] 2) Cut the back skin of the mouse, pull the skin below the knee joint, cut off the knee joint and iliac joint, and put it in PBS.

[0182] 3) Prepare two 10cm petri dishes, place the tissue in the petri dish, and trim the tissue to facilitate the exposure of the bone end.

[0183] 4) Put the treated tissue into another 10cm culture dish and add 1640 medium.

[0184] 5) Prepare a 10ml syringe, fill it with 1640 medium, cut both ends of the femur, and flush the bone marrow cavity with a 1ml syringe, and a long strip of bone marrow or red liquid can be seen flowing out.

[0185] 6) Collect the washing liquid into a 50ml centrifuge tube, rinse the culture dish, centrifuge, 4 degrees, 1200rpm, 5min

[0186] 7) Discard the sup...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to view more

Abstract

The invention relates to an interference sequence-modified TGF-beta1 silent leukemia cell exosome and a preparation method and application thereof. Through expression of TGF-beta1 of a lentivirus vector silent exosome source cell with shRNA, the leukemia cell exogenic exosome, namely LEXTGF-beta1si of which the TGF-beta1 content is regulated down is produced and purified. The transformed leukemia cell exogenic exosome-sensitized dendritic cell is prepared into a DCLEX-TGF-beta1si vaccine. An in vitro and animal model experiment shows that the transformed vaccine is capable of generating more powerful specific anti-leukemia immunoreaction.

Description

technical field [0001] The invention belongs to the field of biotechnology, and in particular relates to a TGF-β1-silenced leukemia cell exosome modified by an interference sequence and a preparation method and application thereof. Background technique [0002] Relapse after treatment of leukemia patients is the main factor affecting the long-term survival of patients, and the root cause is the residual leukemia cells in the body after treatment. The traditional methods mainly rely on high-dose consolidation chemotherapy and allogeneic hematopoietic stem cell transplantation to eliminate the residual leukemia cells in patients in remission, in which the anti-leukemia effect of allogeneic lymphocytes in the transplantation is very important, but this non-specific immunity Graft-versus-host disease is often accompanied by severe graft-versus-host disease, which is the main cause of death in hematopoietic stem cell transplantation. Immunotherapy can specifically remove residua...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/10C12N15/867A61K39/00A61P35/00
CPCA61K39/0011C12N5/0694C12N15/86C12N2510/00C12N2740/15043
Inventor 郝思国黄方
Owner XIN HUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap